Valdecoxib Meta-Analysis Suggests Increased Cardiovascular Risk

Results of a meta-analysis of placebo-controlled valdecoxib (Bextra) studies conducted in surgery and arthritis patients suggest that valdexcoxib use is associated with an increased risk of cardiovascular events — especially stroke.